Plain-English translation of NCT06887517 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lupus Erythematosus, Systemic research guide →This is a research study collecting blood samples and medical records from about 300 people who have been recently diagnosed with lupus, an autoimmune disease that can affect multiple organs. Researchers want to use this information to build a biobank—a carefully organized collection of biological samples and patient data—that will help them develop better tools to predict which lupus patients are likely to develop serious complications like kidney disease, blood clotting problems, or lung issues.
Right now, doctors cannot reliably predict which lupus patients will develop severe organ damage over time. By collecting blood samples and detailed health information from newly diagnosed patients, researchers hope to identify early warning signs and patterns that could help doctors catch dangerous complications before they happen, allowing for earlier treatment and better outcomes.
You likely qualify if…
You likely don't qualify if…
As a participant, you would donate blood samples that will be stored for research, and you would share your medical history and disease records with the study team. The study involves long-term follow-up, meaning researchers will track how your lupus develops over time and may ask you to provide updated medical information periodically. There are no specific medications being tested in this study—this is purely a data and sample collection effort designed to help future lupus patients.
AI-generated summary from trial data · Jun 11, 2026 · Not medical advice
China
Sponsor
Chinese SLE Treatment And Research Group
Enrollment target
~300 participants
Started
February 2025
Primary completion
April 2028
Last updated on clinicaltrials.gov in April 2025.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.